Bingham Private Wealth LLC lessened its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 6.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,025 shares of the company’s stock after selling 146 shares during the quarter. Bingham Private Wealth LLC’s holdings in Procter & Gamble were worth $323,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of the business. MADDEN SECURITIES Corp boosted its holdings in shares of Procter & Gamble by 4.6% in the 2nd quarter. MADDEN SECURITIES Corp now owns 1,531 shares of the company’s stock valued at $244,000 after purchasing an additional 68 shares in the last quarter. Seamount Financial Group Inc. boosted its holdings in shares of Procter & Gamble by 38.3% in the 2nd quarter. Seamount Financial Group Inc. now owns 6,910 shares of the company’s stock valued at $1,101,000 after purchasing an additional 1,915 shares in the last quarter. Bennett Associates Wealth Management acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at $226,000. Drake & Associates LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at $417,000. Finally, Mraz Amerine & Associates Inc. bought a new position in shares of Procter & Gamble in the 2nd quarter valued at $206,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
PG stock opened at $150.47 on Tuesday. The stock has a 50-day moving average price of $155.38 and a 200-day moving average price of $159.84. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market cap of $352.17 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on PG. Wells Fargo & Company dropped their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Berenberg Bank increased their price target on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. BNP Paribas Exane dropped their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research note on Saturday, September 27th. Finally, Barclays dropped their price target on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $173.11.
Get Our Latest Stock Analysis on PG
Insider Transactions at Procter & Gamble
In other news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. This trade represents a 18.11% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Gary A. Coombe sold 10,194 shares of the firm’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the sale, the chief executive officer owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Exceptional Stocks to Build Long-Term Wealth
- How to Buy Gold Stock and Invest in Gold
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.